Urogenital history in veterans exposed to high-dose sulfur mustard. A preliminary study of self-reported data

Urology Journal

Volumn 6, Issue 2, 2009, Pages 114-119

  Soroush, Mohammad Reza ^a   Ghanei, Mostafa ^a   Assari, Shervin ^a   Khoddami Vishteh, Hamid Reza ^b,c  

^a JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^b Medicine and Health Promotion Institute   (Iran)

^c Scientific Writing Network   (Iran)

Author keywords

Chemical warfare; Health care surveys; Mustard gas; Urologic diseases; Veterans

Indexed keywords

CHEMICAL WARFARE AGENT; MUSTARD GAS;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; EXPOSURE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROBABILITY; PROSTATE HYPERTROPHY; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICS; TIME; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; UROLITHIASIS; VETERAN;

ADULT; AGE DISTRIBUTION; AGED; CHEMICAL WARFARE AGENTS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; HEALTH SURVEYS; HUMANS; INCIDENCE; INHALATION EXPOSURE; KIDNEY FAILURE; MALE; MALE UROGENITAL DISEASES; MEDICAL HISTORY TAKING; MIDDLE AGED; MUSTARD GAS; PROBABILITY; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS; URINARY CALCULI; URINARY TRACT INFECTIONS; VETERANS;

EID: 66549129104     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol. 2004;16:491-5.
2. Ghanei M, Vosoghi AA. An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environ Health Perspect. 2002;110:519-21.
3. Ghanei M. Delayed haematological complications of mustard gas. J Appl Toxicol. 2004;24:493-5.
4. Dacre JC, Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev. 1996;48:289-326.
5. Pechura CM, Rall DP. Veterans at risk: the health effects of mustard gas and lewisite. Washington DC: National Academy Press; 199p. 117-8.
6. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol. 2006;99:273-82.
7. Balali-Mood M, Hefazi M, Mahmoudi M, et al. Longterm complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol. 2005;19:713-21.
8. Boursnell JC, Cohen JA, Dixon M, et al. Studies on mustard gas (betabeta'-dichlorodiethyl sulphide) and some related compounds: The fate of injected mustard gas (containing radioactive sulphur) in the animal body. Biochem J. 1946;40:756-64.
9. Davison C, Rozman RS, Smith PK. Metabolism of bisbeta- chloroethyl sulfide (sulfur mustard gas). Biochem Pharmacol. 1961;7:65-74.
10. Davison C, Rozman RS, Bliss L, Smith PK. Studies on the metabolic fate of bis(2-chloroethyl) sulfide (mustard gas) in the mouse and human. Proc Am Assoc Cancer Res. 1957;2:195.
11. Roberts JJ, Warwick GP. Studies of the Mode of Action of Alkylating Agents. Vi. the Metabolism of Bis-2-Chloroethylsulphide (Mustard Gas) and Related Compounds. Biochem Pharmacol. 1963;12:1329-34.
12. Omaye ST, Elsayed NM, Klain GJ, Korte DW, Jr. Metabolic changes in the mouse kidney after subcutaneous injection of butyl 2-chloroethyl sulfide. J Toxicol Environ Health. 1991;33:19-27.
13. Czerny K, Ciszewska-Popiolek B, Mitura K. [Histochemical studies of the kidney of white rats after experimental external application of sulfur mustard gas]. Gegenbaurs Morphol Jahrb. 1990;136:89-9German.
14. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol. 2007;19:451-6.
15. Warren JW, Brown V, Jacobs S, Horne L, Langenberg P, Greenberg P. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology. 2008;71:1085-90.
16. Memikoglu KO, Keven K, Sengul S, Soypacaci Z, Erturk S, Erbay B. Urinary tract infections following renal transplantation: a single-center experience. Transplant Proc. 2007;39:3131-4.
17. Pechura CM, Rall DP. Veterans at risk: the health effects of mustard gas and lewisite. Washington DC: National Academy Press; 199p. 382-5.
18. Vycudilik W. Detection of mustard gas bis(2- chloroethyl)-sulfide in urine. Forensic Sci Int. 1985;28:131-6.
19. Wils ER, Hulst AG, de Jong AL, Verweij A, Boter HL. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J Anal Toxicol. 1985;9:254-7.
20. Drasch G, Kretschmer E, Kauert G, von Meyer L. Concentrations of mustard gas [bis(2-chloroethyl) sulfide] in the tissues of a victim of a vesicant exposure. J Forensic Sci. 1987;32:1788-93.
21. Ghanei M, Alavian SM, Nassiri M, Assari SH. Alanin aminotransferase activity in veterans exposed to sulfur mustard. Iran J Metab Endocrinol. 2007;9:29-35.
22. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113 Suppl 1A:5S-13S.
23. Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM. Urinary tract infection in men. Int J Clin Pharmacol Ther. 2004;42:360-6.
24. Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 1989;110:138-50.
25. Johnson JR. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004;39:873.
26. Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol. Mar 2005;173:848-57.
27. Safarinejad MR. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol. 2008;40:921- 31.
28. Nafar M, Mousavi SM, Mahdavi M, et al. Burden of chronic kidney disease in Iran: a acreening program is of essential need. Iran J Kidney Dis. 2008;2:183-92.
29. Watson AP, Jones TD, Griffin GD. Sulfur mustard as a carcinogen: application of relative potency analysis to the chemical warfare agents H, HD, and HT. Regul Toxicol Pharmacol. 1989;10:1-25.
30. Alpert LK. Preliminary studies with sulfur mustard in human neoplastic diseases. Ann N Y Acad Sci. 1958;68:1223-4.